In a recent study of older adults, Ayala-Guerrero et al. (2022) found significantly higher serum GFAP levels in people with T2D and cognitive impairment, compared to people without diabetes and who were cognitively unimpaired [48]. The gene discussed is GFAP; the disease is type 2 diabetes mellitus.